Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression. - Wikidata - awgldk - TriplyDB

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

http://www.wikidata.org/entity/Q36659255

about

The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells Clinical and pathological implications of miRNA in bladder cancer miRNA dysregulation in cancer: towards a mechanistic understanding microRNA in the development of diabetic complications.Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets Smoking status impacts microRNA mediated prognosis and lung adenocarcinoma biology miR-19a acts as an oncogenic microRNA and is up-regulated in bladder cancer Circulating miRNAs in cancer: from detection to therapy.MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1 Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study.The Roles of MicroRNAs in Breast Cancer microRNA regulation in cancer: One arm or two arms?miR-339-3p inhibits proliferation and metastasis of colorectal cancer Aberrantly expressed miR-582-3p maintains lung cancer stem cell-like traits by activating Wnt/β-catenin signalling Overexpression of ATP1B1 predicts an adverse prognosis in cytogenetically normal acute myeloid leukemia miR-582-5P induces colorectal cancer cell proliferation by targeting adenomatous polyposis coli.Synthetic pre-microRNAs reveal dual-strand activity of miR-34a on TNF-α.The role of microRNAs in the regulation of cancer stem cells.MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.Upregulation of miR-582-5p inhibits cell proliferation, cell cycle progression and invasion by targeting Rab27a in human colorectal carcinoma.MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility.miR-582-5p inhibits proliferation of hepatocellular carcinoma by targeting CDK1 and AKT3.The Role of MicroRNAs and Their Targets in Osteoarthritis.Up-regulation of miR-582-5p regulates cellular proliferation of prostate cancer cells under androgen-deprived conditions.No influence of exogenous hyaluronan on the behavior of human cancer cells or endothelial cell capillary formation.microRNA regulation of human pancreatic cancer stem cells.Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype.Crosstalk in competing endogenous RNA network reveals the complex molecular mechanism underlying lung cancer.The delta opioid peptide D-Alanine 2, Leucine 5 Enkephaline (DADLE)-induces neuroprotection through cross-talk between the UPR and pro-survival MAPK-NGF-Bcl2 signalling pathways via modulation of several micro-RNAs in SH-SY5Y cells subjected to ER s Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.Aberrant expression of microRNA induced by high-fructose diet: implications in the pathogenesis of hyperlipidemia and hepatic insulin resistance.Defensive effect of microRNA-200b/c against amyloid-beta peptide-induced toxicity in Alzheimer's disease models.microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer

P2860

Q26752473-A74216C2-222E-4409-B9D9-4D8AC593E6B6 Q27004262-5BEE7AB5-E35A-48F5-AF14-A9699F7F0CBE Q27026420-148F8A96-A78A-47A2-B084-6B97173ECF43 Q30353835-F621128F-FD6E-4C02-A068-EBFB95E2AB76 Q30488342-F1876477-C8B4-4F9C-8FF1-6B996968AE49 Q34436424-A10F56A3-0974-40D7-9EB1-2F950C14D71E Q34544501-91D8CEF1-A1D6-4BF7-82E0-28DF349A719A Q34728385-D38475C9-FC49-4E3D-B01A-A658F0A5BC1F Q34733682-E593FC2D-38B6-479B-9039-97B313D8B8AC Q35108097-7B950490-67F2-434B-AF73-C9116560441D Q35621416-6661F55D-1322-4FFD-92FA-38994698ED25 Q35818407-5241263B-F38F-45A5-B014-0D62616B4D35 Q35836476-01AF5D7B-D6C8-4533-B59E-98E7B19060D6 Q36335831-19751283-BABE-4A10-9483-DADB8FC7A90D Q36341597-703CF1CB-6261-4622-869D-DE15A6401D28 Q36771874-69EE9DC2-1C7D-4225-B101-A834E37BE825 Q37233140-692F3D61-16F1-45EF-BFC9-425EDDE9F4E0 Q37400278-15296646-9545-499E-A57B-119651FDD412 Q37428403-F66285C8-D6BD-4B80-85BD-61737C61AE8B Q37462436-E7FBB797-BF74-4144-B7EC-B44CF9EFC02F Q37550211-E15B940C-BA02-4887-B428-8853AD8E79E5 Q37686233-CA1B8CA6-D159-4815-B1A2-C3BF2E8D7BC0 Q38834380-7085F4F8-5285-4FFA-AC19-66E3457A3F47 Q38842182-AB45F16F-9AE5-4E0B-A443-B86E59D725AB Q38871765-475ED6F3-3297-4E42-BAD9-424E03CB6B35 Q38893214-83EF845D-DC9D-4A80-8D78-5CBD121402F6 Q38960954-8AC7CFA7-5486-47F2-92AC-B6640AE9BC0B Q38988636-3C3F35C9-ECE0-44DD-9BBF-62008810893C Q39143971-591A26D2-F97C-441F-AC6E-06643838C3DB Q40928156-48901EA8-D781-4CA1-8B6B-A89565FA82B5 Q47108123-90DEB424-E765-4DD0-B5DC-7902B0C194B4 Q47261323-DD60C87B-F7E4-4A51-8A58-2BC2E0A2F70C Q48372498-2D836AF4-67BC-4213-A425-F43ECD5817B3 Q50963304-1BF1524D-1161-4D58-8246-76A21C39F9F7 Q54111592-0128B3E0-EA4C-4907-B6F5-10EF6212FE1B Q58101121-FC11FCD0-E727-4ACF-AD44-FFB2E507198E

P2860

Therapeutic effects of microRNA-582-5p and -3p on the inhibition of bladder cancer progression.

http://www.wikidata.org/entity/Q36659255

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Therapeutic effects of microRN ...... of bladder cancer progression.

@ast

Therapeutic effects of microRN ...... of bladder cancer progression.

@en

type

label

Therapeutic effects of microRN ...... of bladder cancer progression.

@ast

Therapeutic effects of microRN ...... of bladder cancer progression.

@en

prefLabel

Therapeutic effects of microRN ...... of bladder cancer progression.

@ast

Therapeutic effects of microRN ...... of bladder cancer progression.

@en

P1433

Q36659255-94792C77-C92E-4774-9FBC-AFB7E0579D60

P1476

Q36659255-ACF48033-03A6-4A59-93EE-B1CA3B0ADA37

P2093

Q36659255-1191C8AF-C3D5-40C4-ACB0-0585973148CE

Q36659255-21E8BFFA-91FD-4593-B9DC-F6BAF9EA5110

Q36659255-4CEB805E-5EC4-4E4E-AF38-712C4602FF21

Q36659255-63E68BEB-47CE-4F41-964C-5F4C04C61234

Q36659255-7B4EDF48-72F6-4311-8C6A-60AF2701AFA5

Q36659255-86DC61C2-AEEA-49BC-B3DB-407A3C6887F9

Q36659255-926A0A4C-4C8F-4AAC-99C2-2EB0AC2BF49E

Q36659255-9494476F-3AC5-4AD8-B2C9-BE446D117F89

Q36659255-9D2F0775-059E-4F1C-B768-076CE8FE9D18

Q36659255-A8BF3748-2DFE-4DAA-8C75-CC97845B63B8

P2860

Q36659255-05EAD37F-5B8C-4D27-AB6D-9C3E5CA2579A

Q36659255-090AD051-4712-4D26-85A0-0CC52882E773

Q36659255-0BC9E817-8E1D-4AFC-91DD-B051931D5944

Q36659255-0C4C61C6-3903-41BB-B2FC-10731C9E72C4

Q36659255-1825764A-ABDF-49D3-B0FF-A7A375DB7EBE

Q36659255-23658457-1364-47E5-AA7B-97474081B8F1

Q36659255-2D70F9EE-575D-4586-B277-CB1B6C4CC49B

Q36659255-2E5842F6-09C1-426B-85E2-6DFF5D2892BE

Q36659255-3856E5B0-17FA-4C8B-92DC-2DA716A6A0D5

Q36659255-412F5973-A99A-4126-9E77-2F46C90D4D6C

P304

Q36659255-BB50EC2F-2C82-471D-A490-A7FE7DF16946

P31

Q36659255-88C8EEFA-3460-4B32-A1D9-B2FC3059B689

P356

Q36659255-C894DB4B-44D5-480A-BA78-FA12B4514B57

P433

Q36659255-4C48DB4E-3A89-4F6F-8CC2-4CC2AA0A6B9B

P478

Q36659255-5C78401B-B466-4C75-912E-B7C3F0206270

P577

Q36659255-38D631B3-C574-409A-A767-D32C4D1E8DCE

P698

Q36659255-F8814BD2-D04E-41C5-A105-DDB82C6D7771

P921

Q36659255-147E4C8C-9130-4302-A4D0-31BB562FEA2A

P932

Q36659255-CBEB66A0-6B4D-4A46-BB36-91543C2098BE

P356

P1433

Molecular Therapy

P1476

Therapeutic effects of microRN ...... of bladder cancer progression.

@en

P2093

Fumitaka Takeshita

http://www.w3.org/2001/XMLSchema#string

Haruna Naruoka

http://www.w3.org/2001/XMLSchema#string

Hideo Sasaki

http://www.w3.org/2001/XMLSchema#string

Junichi Yano

http://www.w3.org/2001/XMLSchema#string

Kae Fujiwara

http://www.w3.org/2001/XMLSchema#string

Kazuki Kitajima

http://www.w3.org/2001/XMLSchema#string

Keita Uchino

http://www.w3.org/2001/XMLSchema#string

Miki Yoshiike

http://www.w3.org/2001/XMLSchema#string

Nobuyoshi Kosaka

http://www.w3.org/2001/XMLSchema#string

Ryou-U Takahashi

http://www.w3.org/2001/XMLSchema#string

P2860

LRRK2 directly phosphorylates Akt1 as a possible physiological substrate: impairment of the kinase activity by Parkinson's disease-associated mutations

Rab27a and Rab27b control different steps of the exosome secretion pathway

miRBase: microRNA sequences, targets and gene nomenclature

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers

Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes

The impact of microRNAs on protein output

Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans

Current prospects for RNA interference-based therapies

DIXDC1 isoform, l-DIXDC1, is a novel filamentous actin-binding protein

P304

610-619

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2012.269

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23295946

http://www.w3.org/2001/XMLSchema#string

P921

P932

3589153

http://www.w3.org/2001/XMLSchema#string